U.S. markets closed
  • S&P 500

    4,513.04
    -53.96 (-1.18%)
     
  • Dow 30

    34,022.04
    -461.68 (-1.34%)
     
  • Nasdaq

    15,254.05
    -283.64 (-1.83%)
     
  • Russell 2000

    2,147.42
    -51.49 (-2.34%)
     
  • Crude Oil

    66.55
    +0.98 (+1.49%)
     
  • Gold

    1,782.10
    -2.20 (-0.12%)
     
  • Silver

    22.36
    +0.03 (+0.12%)
     
  • EUR/USD

    1.1320
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.4340
    -0.0090 (-0.62%)
     
  • GBP/USD

    1.3278
    +0.0000 (+0.00%)
     
  • USD/JPY

    112.9200
    +0.1400 (+0.12%)
     
  • BTC-USD

    57,026.28
    -255.86 (-0.45%)
     
  • CMC Crypto 200

    1,442.71
    -26.37 (-1.79%)
     
  • FTSE 100

    7,168.68
    +109.23 (+1.55%)
     
  • Nikkei 225

    27,693.00
    -242.62 (-0.87%)
     

Analysts say Boston Scientific faces 'higher level of exposure' to risk

·2 min read
Analysts say Boston Scientific faces 'higher level of exposure' to risk
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Boston Scientific Corp. is expected to report its Q3 earnings on Wednesday, and the medical device manufacturer is widely expected to post year-over-year growth as it works to bounce back from last year's Covid-19-driven hit.